Jan 28, 2009 -
When it comes to beauty, I'll admit that I can always learn more about having a healthy complexion. So when I heard of a book that Japanese women consider to be their go-to guide to skin care, I took notice. Esthetician Chizu Saeki's The Japanese Skincare Revolution ($14) has recently been translated to English, and it draws upon her 45 years of beauty industry experience.
- 15 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Hepatitis A
- Hepatitis B and D
- Hepatitis C
- Autoimmune Hepatitis
- Symptom Management
- Outlook
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2006, the FDA approved telbivudine (Tyzeka), a new type of nucleoside analog drug, for treatment of chronic hepatitis B. There are now six drugs approved for hepatitis B treatment.
- In 2007, the FDA approved HepaGam B, an intravenous immune globulin drug, for preventing hepatitis B recurrence following liver transplantation.
Drug Warning
In 2007, the FDA revised the prescribing label for entecavir (Baraclude), a drug used to treat hepatitis B. The new label advises against using entacavir in patients infected with both hepatitis B and HIV who are not receiving antiretroviral (anti-HIV) therapy.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Body's Response
- Complications
- Conditions with Similar Sym...
- Treatment
- Risk Factors
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
- Some people are pre-programmed for a heightened response to stress by conditions in the womb. Pregnant women under stress who eat a diet high in protein and low in carbohydrates have babies with higher cortisol levels. Later on, these levels increase in response to stress.
- The impact of stress on the heart and circulation system is becoming more clear.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes and Risk Factors
- Triggers
- Diagnosis
- Treatment: Acute Gout Attac...
- Treatment: Preventing Attac...
- Other Treatments
- Lifestyle Changes
- Complications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Types of Gout:
There are two types of gout -- primary and secondary.
- Primary gout: The cause is usually unknown. However, primary gout is likely the result of a combination of genetic, hormonal, and dietary factors.
- Secondary gout: Secondary gout is caused by medications or medical conditions that cause an increase in the serum (blood) levels of uric acid.
Risk Factors:
Risk factors for gout include:
- Advancing age
- Male gender
- Family history of the condition
- Obesity
- Use of certain drugs, including diuretics, aspirin, cyclosporine, or levodopa
- Drinking a large amount of alcohol, particularly beer
- Exposure to lead
- Organ transplants
- Thyroid problems
Symptoms of a Gout Attack:
Symptoms of a gout attack include:
- Severe pain at and around the joint
- May feel like "crushing" or a dislocated bone
- Walking and the weight of bed sheets may be unbearable
- Usually takes 8 - 12 hours to develop
- Occurs late at night or early in the morning and may wake you up
- Swelling that may extend beyond the joint
- Red, shiny, tense skin over the affected area, which may peel after a few days
- Chills and mild fever, loss of appetite, and feelings of ill health
Research News
A large study found that people with gout are at an increased risk of having metabolic syndrome.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diphtheria, Tetanus, and Pe...
- Measles, Mumps, and Rubella...
- Varicella-Zoster Virus (Chi...
- Varicella-Zoster Virus (Shi...
- Hepatitis A
- Hepatitis B
- Pneumococcal Pneumonia
- Poliomyelitis
- Viral Influenza
- Haemophilus Influenzae Type...
- Human Papillomavirus (HPV)...
- Rotavirus
- Smallpox
- Other Vaccinations
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccines
- The Centers for Disease Control and Prevention now recommends that children receive 2 doses of the varicella-zoster (Chickenpox) vaccine: the initial vaccine between ages 12 - 15 months, and a booster between 4 - 6 years. Children aged 12 and older and adults who have not had the vaccine should receive 2 doses. Immunization guidelines were changed following research that indicated the effectiveness of the vaccine declines over time.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Diagnosis
- Risk Factors
- Complications
- Treatment
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Congenital Hypothyroidism and Maternal Hyperthyroidism
Thyroid-lowering medications used for treating Graves’ disease, the most common cause of hyperthyroidism (overactive thyroid), can cause babies to be born with hypothyroidism (underactive thyroid). Research presented at the 2006 annual meeting of the American Thyroid Association suggests that hyperthyroidism can be effectively managed during pregnancy without causing newborn hypothyroidism. The researchers suggest that:
- Pregnant women with Graves’ disease should take the lowest possible dose of their thyroid medication
- It is safe for women with Graves’ disease to maintain thyroid levels in the upper-normal range while pregnant
Low-Normal Thyroid and Metabolic Syndrome
- Thyroid levels in the low-normal range may increase the risk of unhealthy cholesterol levels, high blood sugar, and abdominal obesity -- indicators of metabolic syndrome -- according to a 2006 study in the Journal of Clinical Endocrinology and Metabolism.
- Metabolic syndrome is a cluster of conditions, (including abdominal obesity, high blood sugar, and unhealthy cholesterol levels), which increases the risk for heart disease.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Complications
- Risk Factors
- Prevention
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccine News:
- On September 28, 2007, the U.S. Food and Drug Administration (FDA) approved a new brand of inactivated influenza ("flu") vaccine, Alfuria, for adults aged 18 years or older. This vaccine is given by injection.
- On September 19, 2007, the FDA approved the use of the live flu vaccine (FluMist) in healthy children as young as 2 years of age.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Levadopa (L-dopa)
- Other Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the FDA approved the first skin patch drug for treatment of Parkinson’s disease. Transdermal rotigotine (Neupro) is a dopamine agonist drug that may help improve symptoms of early-stage Parkinson’s disease. The patch is applied daily.
- Rivastigimine (Exelon), an Alzheimer’s disease drug, was approved in 2006 for treatment of mild-to-moderate dementia associated with Parkinson’s disease.
Drug Withdrawal
In 2007, the FDA withdrew the dopamine agonist pergolide (Permax) from the market due to safety concerns.
- 2 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Risk Factors
- Symptoms
- Conditions with Similar Sym...
- Screening and Diagnosis
- Tests to Determine Severity...
- Treatment
- Treatment Options by Stagin...
- Treatment for Localized Pro...
- Surgery
- Radiation Treatments
- Options if Treatments Fail...
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Guidelines for Localized Prostate Cancer
In 2007, the American Urological Association (AUA) released updated guidelines for treatment of localized prostate cancer. The guidelines recommend that:
- Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
- Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
- Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.
New Guidelines for Androgen Deprivation Therapy
- The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms.
- 0 Comments
Sep 03, 2008 -
Overview
- Definition
- Alternative Names
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Support Groups
- Expectations (prognosis)
- Complications
- Calling your health care provider
- Prevention
Illustrations
Male reproductive anatomy
Male urinary tract
BPH
Prostate cancer
PSA blood test
Prostatectomy - series
TURP - series
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Prostate cancer is cancer that grows in prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around the urethra, the tube that carries urine out of the body.
- 0 Comments